← Eichor
Study identifier: NCT06020248 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Melanin and Dermal Uptake of Thirdhand Cigarette Smoke

Condition: Healthy  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants60
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersYes

About this study

This is a pilot study of the effects of dermal melanin on dermal uptake and retention of nicotine. The initial hypothesis is that higher levels of dermal melanin will correlate with lower uptake and longer retention of nicotine in the skin and body.

This description comes directly from the study's public registry record.

Talk to the study team

Suzaynn F Schick, PhD  ·  415-514-3535  ·  suzaynn@gmail.com

Abel Huang, BS  ·  (415) 514-9011  ·  abel.huang@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Zuckerberg San Francisco General HospitalSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06020248